Clinical Diagnostics Market Report 2026

Clinical Diagnostics Market Overview

• Clinical Diagnostics market size has reached to $81.74 billion in 2025 • Expected to grow to $115.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Rising Chronic Disease Incidence Driving Growth In The Clinical Diagnostics Market • Market Trend: Innovative Technologies In Clinical Diagnostics Real-Time Biosensors • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clinical Diagnostics Market?

Clinical diagnostics refers to identifying, diagnosing, and monitoring diseases or medical conditions in patients through various laboratory tests, imaging techniques, and other diagnostic tools. It involves the analysis and interpretation of patient samples, medical history, and clinical data to provide accurate and timely information to aid in diagnosing, treating, and managing diseases. The main tests of clinical diagnostics are lab tests, imaging tests, and others. Lab tests are diagnostic procedures performed on samples such as blood, urine, or tissue to identify diseases, monitor health conditions, or assess the effectiveness of treatments. The various products include instruments, reagents, and others and are used by various end users such as hospital laboratories, diagnostic laboratories, point-of-care testing facilities, and other settings.

What Is The Clinical Diagnostics Market Growth Forecast?

The clinical diagnostics market size is expected to see strong growth in the next few years. It will grow to $115.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing adoption of precision diagnostics, rising investments in advanced imaging systems, expansion of home-based diagnostic testing, growing demand for rapid diagnostic accuracy, increased integration of ai in diagnostics. Major trends in the forecast period include increasing adoption of molecular and genetic diagnostics, rising demand for rapid point-of-care testing, growing integration of imaging and laboratory diagnostics, expansion of automated diagnostic platforms, enhanced focus on early disease detection.

Global Clinical Diagnostics Market Segmentation

1) By Test: Lab Test, Imaging Test, Other Tests 2) By Product: Instruments, Reagents, Other Products 3) By End User: Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care Testing, Other End Users Subsegments: 1) By Lab Test: Blood Tests, Urine Tests, Genetic Tests, Biopsy And Cytology Tests 2) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), CT Scan (Computed Tomography), Ultrasound, PET (Positron Emission Tomography) Scan 3) By Other Tests: Molecular Diagnostics, Point-Of-Care Tests, Pregnancy Tests, Allergy Tests

What Is The Driver Of The Clinical Diagnostics Market?

The rising incidence of chronic diseases is expected to propel the growth of the clinical diagnostics market going forward. Chronic diseases are long-lasting conditions that can usually be controlled but not cured, often requiring ongoing medical attention, and limiting activities of daily living. The rising prevalence of chronic diseases is primarily driven by factors such as unhealthy lifestyles, socioeconomic disparities, and aging populations, which collectively exacerbate the risk of conditions such as heart disease, diabetes, and cancer. Clinical diagnostics are used for chronic diseases to accurately diagnose conditions, monitor disease progression, manage treatment, detect complications early, personalize medicine, assess risk factors, and support patient education and self-management. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the rising incidence of chronic diseases drives the clinical diagnostics industry.

Key Players In The Global Clinical Diagnostics Market

Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

Global Clinical Diagnostics Market Trends and Insights

Major companies operating in the clinical diagnostics market are focused on developing innovative products, such as advanced liquid biopsy assays, to enable comprehensive genomic profiling of solid tumors. A liquid biopsy assay is a minimally invasive test that analyzes blood samples to detect cancer-related biomarkers, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), providing insights for diagnosis, treatment monitoring, and personalized medicine. For instance, in November 2023, Illumina Inc., a US-based biotechnology company, launched TruSight Oncology 500 ctDNA v2, an advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors. This innovative assay allows for the detection of genetic mutations and alterations in tumors with high precision, providing detailed insights into the tumor's molecular profile. The assay enhances the ability to monitor tumor dynamics and adapt treatment plans, accordingly, improving personalized treatment strategies. The assay is designed to deliver rapid and reliable results, facilitating timely clinical decision-making and advancing the field of cancer diagnostics.

What Are Latest Mergers And Acquisitions In The Clinical Diagnostics Market?

In December 2024, Metropolis Healthcare Ltd., an India-based diagnostic services provider, acquired a 100% stake in Core Diagnostics for $0.03 billion (₹247 crore). With this acquisition, Metropolis Healthcare aims to strengthen its position in the high-end specialized testing segment, expand its capabilities in advanced molecular and genomic diagnostics, and enhance its overall portfolio of premium diagnostic solutions across India. Core Diagnostics is an India-based specialty diagnostics company offering high-end clinical testing services, including genomics, oncology, and infectious disease diagnostics.

Regional Outlook

North America was the largest region in the clinical diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Diagnostics Market?

The clinical diagnostics market includes revenues earned by entities by providing services such as genetic testing, molecular diagnostics, pathology services, microbiology testing, and immunology testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The clinical diagnostics market also includes the sale of imaging devices, laboratory analyzers, point-of-care testing devices, endoscopy equipment, and respiratory diagnostic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Diagnostics Market Report 2026?

The clinical diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.